Compare NPCE & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | CLPT |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 494.6M |
| IPO Year | 2021 | 2009 |
| Metric | NPCE | CLPT |
|---|---|---|
| Price | $15.35 | $10.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $18.33 | ★ $20.00 |
| AVG Volume (30 Days) | 170.2K | ★ 641.1K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $99,986,000.00 | $36,971,000.00 |
| Revenue This Year | $0.90 | $45.67 |
| Revenue Next Year | $24.46 | $19.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.13 | 17.78 |
| 52 Week Low | $7.56 | $8.27 |
| 52 Week High | $18.97 | $30.10 |
| Indicator | NPCE | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 62.42 | 53.11 |
| Support Level | $15.25 | $10.02 |
| Resistance Level | $15.71 | $11.74 |
| Average True Range (ATR) | 0.68 | 0.56 |
| MACD | 0.21 | 0.21 |
| Stochastic Oscillator | 95.38 | 94.68 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.